Molecular Oncology
Volume 2, Issue 3 , Pages 250-260 , October 2008

Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer

  • Jane Bayani

      Affiliations

    • Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario, M5G 2M9, Canada
    • ,
  • Miltiadis Paliouras

      Affiliations

    • Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5T 3L9, Canada
    • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada
    • ,
  • Chris Planque

      Affiliations

    • Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5T 3L9, Canada
    • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada
    • ,
  • Shannon J.C. Shan

      Affiliations

    • The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    • ,
  • Cassandra Graham

      Affiliations

    • Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario, M5G 2M9, Canada
    • ,
  • Jeremy A. Squire

      Affiliations

    • Department of Pathology and Molecular Medicine, Richardson Lab. Queens University, Kingston, Ontario K7L 3N6, Canada
    • ,
  • Eleftherios P. Diamandis

      Affiliations

    • Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5T 3L9, Canada
    • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1L5, Canada
    • Corresponding Author InformationCorresponding author. Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto M5G 1X5, Ontario, Canada. Tel.: +1 416 586 8443; fax: +1 416 619 5521.

Received 4 June 2008 ,Accepted 14 July 2008.

References 

  1. Adeyinka A, Kytola S, Mertens F, Pandis N, Larsson C. Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases. Int. J. Mol. Med. 2000;5:235–240
  2. Anisowicz A, Sotiropoulou G, Stenman G, Mok SC, Sager R. A novel protease homolog differentially expressed in breast and ovarian cancer. Mol. Med. 1996;2:624–636
  3. An International System for Human Cytogenetic Nomenclature . In:  Shaffer LG,  Tommerup N editor. Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Basel: S Karger AG; 2005;
  4. Baudis M. Progenetix cytogenetics online database. 2007.
  5. Bayani J, Squire JA. Chapter 22: Cell biology of chromosomes and nuclei. In:  Morgan K editors. Current Protocols in Cell Biology. Bethesda, MD: John Wiley & Sons, Inc.; 2000;
  6. Bayani J, Brenton JD, Macgregor PF, et al. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res. 2002;62:3466–3476
  7. Beheshti B, Karaskova J, Park PC, Squire JA, Beatty BG. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping. Mol. Diagn. 2000;5:23–32
  8. Bickmore WA, Teague P. Influences of chromosome size, gene density and nuclear position on the frequency of constitutional translocations in the human population. Chromosome Res. 2002;10(8):707–715
  9. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikrein in cancer. Nat. Rev. Cancer. 2004;4:876–890
  10. Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2004;2:257–280
  11. Cremer T, Kreth G, Koester H, Dietzel S, Fakan S. Chromosome territories, interchromatin domain compartment, and nuclear matrix: an integrated view of the functional nuclear architecture. Crit. Rev. Eukaryot. Gene. Expr. 2000;10:179–212
  12. Cremer T, Kupper K, et al. Higher order chromatin architecture in the cell nucleus: on the way from structure to function. Biol. Cell. 2004;96:555–567
  13. Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J. Clin. Endocrinol. Metab. 1992;75:1046–1053
  14. Craig JM, Bickmore WA. The distribution of CpG islands in mammalian chromosomes. Nat. Genet. 1994;7:376–382
  15. Diamandis EP, Yousef GM. Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 2002;48:1198–1205
  16. Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP. Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells. Tumour Biol. 2004;25:193–199
  17. Haese A, Graefen M, Becker C, et al. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer. Prostate. 2003;54:181–186
  18. Kytölä S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, et al. Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer. 2000;28:308–317
  19. Magklara A, Mellati AA, Wasney GA, et al. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem. Biophys. Res. Commun. 2003;307:948–955
  20. Mitelman F, Johansson B, et al. Mitelman Database of Chromosome Aberrations in Cancer. 2006.
  21. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer. 2007;7:233–245
  22. Neve RM, Chin K, Fridlyand J, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10:515–527
  23. Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, et al. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br. J. Cancer. 2004;91:725–731
  24. Paliouras M, Diamandis EP. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines. Breast Cancer Res. Treat. 2007;102:7–18
  25. Paliouras M, Borgono CA, Diamandis EP. Human tissue kallikreins: The cancer biomarker family. Cancer Lett. 2007;249:61–79
  26. Pampalakis G, Sotiropoulou G. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol. Chem. 2006;387:773–782
  27. Pampalakis G, Diamandis EP, Sotiropoulou G. The epigenetic basis for the aberrant expression of kallikreins in human cancers. Biol. Chem. 2006;387:795–799
  28. Pandis N, Jin Y, Gorunova L, et al. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer. 1995;12:173–185
  29. Rao PH, Harris CP, Yan Lu X, et al. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes Cancer. 2002;33:123–132
  30. Rummukainen J, Kytola S, Karhu R, Farnebo F, Larsson C, Isola JJ. Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping. Cancer Genet. Cytogenet. 2001;126:1–7
  31. Sadoni N, Langer S, Fauth C, et al. Nuclear organization of mammalian genomes. Polar chromosome territories build up functionally distinct higher order compartments. J. Cell Biol. 1999;146:1211–1226
  32. Sasaki H, Kawano O, Endo K, et al. EGFRvIII mutation in lung cancer correlates with increased EGFR copy number. Oncol. Rep. 2007;17:319–323
  33. Selvarajah S, Yoshimoto M, Park PC, et al. The breakage–fusion–bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma. Chromosoma. 2006;115:459–467
  34. Shaw JLV, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 2007;53:423–432
  35. Shinoda Y, Kozaki KI, Imoto I, et al. Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci. 2007;98:1078–1086
  36. Sidiropoulos M, Pampalakis G, Sotiropoulou G, et al. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers. Tumour Biol. 2005;26:324–336
  37. Taetle R, Aickin M, Panda L, et al. Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases. Genes Chromosomes Cancer. 1999;25:46–52
  38. Taetle R, Aickin M, Yang JM, et al. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer. 1999;25:290–300
  39. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–648
  40. Tomlins SA, Mehra R, Rhodes DR, et al. TMPRSS2:ETVA4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res. 2006;66:3396–3400
  41. van Bokhoven A, Caires A, Maria MD, Schulte AP, Lucia MS, Nordeen SK, et al. Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines. Prostate. 2003;57:226–244
  42. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science. 2001;291:1304–1351
  43. Wang Y, Xue H, Cutz JC, et al. An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line. Lab. Invest. 2005;85:1392–1404
  44. Yoshimoto M, Cutz JC, Nuin PA, et al. Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias. Cancer Genet. Cytogenet. 2006;169:128–137
  45. Yousef GM, Chang A, Scorilas A, Diamandis EP. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun. 2000;276:125–133
  46. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function and association to disease. Endocr. Rev. 2001;22:184–204

PII: S1574-7891(08)00091-4

doi: 10.1016/j.molonc.2008.07.001

Molecular Oncology
Volume 2, Issue 3 , Pages 250-260 , October 2008

Article Tools

* Image Usage & Resolution